Csrp1-KO Mouse
一般名
Csrp1-KO
製品ID
S-KO-01672
背景情報
C57BL/6JCya
系統ID
KOCMP-13007-Csrp1-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Csrp1-KO Mouse（カタログ番号S-KO-01672）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Csrp1-KO
系統ID
KOCMP-13007-Csrp1-B6J-VA
遺伝子名
製品ID
S-KO-01672
遺伝子別名
CRP1, Csrp
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 1
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000097561
NCBIトランスクリプトID
NM_001360782
ターゲット領域
Exon 3~4
有効領域の大きさ
~2.7 kb
遺伝子研究の概要
Csrp1, or Cysteine and Glycine-rich Protein 1, belongs to the cysteine-rich protein family and contains a unique double-zinc finger motif. It is important for development and cellular differentiation, and is a marker of smooth muscle lineages [1,2]. Csrp1 has been implicated in various biological processes such as cell morphology regulation via interactions with Dishevelled 2 (Dvl2) and Diversin (Div) in the noncanonical Wnt and JNK pathways [4].
In diseases, abnormal Csrp1 expression is associated with poor prognosis in colon cancer, where higher expression is related to a mesenchymal, stroma-rich tumor profile, epithelial-to-mesenchymal transition (EMT), and a specific consensus molecular subtype (CMS4) [1]. In colon adenocarcinoma, it promotes tumor growth and migration, and higher expression indicates a worse prognosis [2]. In acute myeloid leukemia, it is an independent prognostic factor, correlates with immune-related pathways, and shows differential sensitivity to drugs [3,6]. In prostate cancer, low Csrp1 expression promotes the progression from hormone-sensitive to castration-resistant prostate cancer [5]. In neuroblastoma, it is involved in differentiation, apoptosis, and innate immunity, and can enhance the effects of combination therapies [7]. In cattle, variants of Csrp1 are associated with growth and carcass traits [8].
In conclusion, Csrp1 is crucial for development and cellular differentiation, with its abnormal expression linked to various cancers and hematological diseases. Studies on Csrp1 in different genetic models, though not specifically KO/CKO mouse models in the provided references, have enhanced our understanding of its role in disease progression, potentially guiding future therapeutic strategies.
References:
1. Demirkol Canli, Seçil. 2023. CSRP1 expression is associated with a mesenchymal, stroma-rich tumor profile and poor prognosis in colon cancer. In Turkish journal of medical sciences, 53, 1678-1689. doi:10.55730/1300-0144.5736. https://pubmed.ncbi.nlm.nih.gov/38813484/
2. Yu, Senlong, Zhao, Haifeng, Meng, Hongjie, Bian, Tianhua, Ruan, Canping. 2023. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis. In Genetics research, 2023, 8586507. doi:10.1155/2023/8586507. https://pubmed.ncbi.nlm.nih.gov/37113556/
3. Zhao, Chunxia, Wang, Yulu, Wang, Huan, Schmidt-Wolf, Ingo G H, Wang, Zifeng. 2024. CSRP1 gene: a potential novel prognostic marker in acute myeloid leukemia with implications for immune response. In Discover oncology, 15, 248. doi:10.1007/s12672-024-01088-9. https://pubmed.ncbi.nlm.nih.gov/38937285/
4. Miyasaka, Kota Y, Kida, Yasuyuki S, Sato, Takayuki, Minami, Mari, Ogura, Toshihiko. 2007. Csrp1 regulates dynamic cell movements of the mesendoderm and cardiac mesoderm through interactions with Dishevelled and Diversin. In Proceedings of the National Academy of Sciences of the United States of America, 104, 11274-9. doi:. https://pubmed.ncbi.nlm.nih.gov/17592114/
5. Pan, Chenxi, Wang, Wei, He, Yi, Yang, Bo. 2025. Identification of CSRP1 as novel biomarker for hormone-sensitive prostate cancer by the combination of clinical and functional research. In Cancer cell international, 25, 65. doi:10.1186/s12935-025-03708-y. https://pubmed.ncbi.nlm.nih.gov/39994616/
6. Hao, Qianqian, Liu, Yu, Liu, Yajun, Wang, Shujuan, Sun, Ling. 2024. Cysteine- and glycine-rich protein 1 predicts prognosis and therapy response in patients with acute myeloid leukemia. In Clinical and experimental medicine, 24, 57. doi:10.1007/s10238-023-01269-w. https://pubmed.ncbi.nlm.nih.gov/38546813/
7. Lin, Yu-Han, Jiang, Jyun-Hong, Chuang, Hui-Ching, Lian, Wei-Shiung, Chuang, Jiin-Haur. . The Involvement of CSRP1 in Neuroblastoma Differentiation and Apoptosis Impacting Tumor-Suppressive Therapeutic Responses. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 39, e70521. doi:10.1096/fj.202500403R. https://pubmed.ncbi.nlm.nih.gov/40198006/
8. He, Hua, Liu, Xiao-lin, Zhang, Hui-lin, Liu, Yu, Chen, Ling. 2013. SNV and haplotype analysis reveals new CSRP1 variants associated with growth and carcass traits. In Gene, 522, 206-13. doi:10.1016/j.gene.2013.03.030. https://pubmed.ncbi.nlm.nih.gov/23537997/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。